Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: Results of the PRO-R-IPI study
Publication date:
2015
Publisher version:
Citación:
Clinical Lymphoma, Myeloma and Leukemia, 15(7), p. 398-403 (2015); doi:10.1016/j.clml.2015.02.029
Descripción física:
p. 398-403
ISSN:
Collections
- Artículos [35511]